# Vexev

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/vexev-pty

- Industry: Medical Devices & Equipment
- Headquarters: Australia
- Website: www.vexev.com
- Total disclosed funding: $4.6M
- Latest round: Seed (Jan 26, 2022)
- Investors on record: 3

## About

Based in Australia, Vexev Pty Ltd develops vascular imaging technology for the assessment and monitoring of vascular access and blood flow. Co- Founded in 2018 by Dr John Carroll (CEO) and Dr Eamonn Colley (CEO), the company develops autonomous vascular imaging solutions for healthcare providers. In August 2026, Vexev Pty Ltd raised USD 6 million in venture funding from TreeArc Investment Group, TEN13, Bioshore Ventures, Alumni Ventures, Blackbird Ventures, Neotribe Ventures, Startmate, and Horizon. 
Vexev Pty Ltd develops vascular imaging solutions. Its product, VxWave, is an autonomous ultrasound system that uses robotics, machine learning, and ultrasound technology to support vascular imaging. The system is designed for use in vascular access assessment and monitoring, including applications for dialysis patients. Vexev serves healthcare providers, dialysis centers, and healthcare institutions in the United States.
The company plans to use the August 2026 funding to support the regulatory activities, manufacturing scale-up and commercialization.

## Funding rounds

- Seed, Jan 26, 2022, $3.7M — Blackbird, NeoTribe Ventures
- Seed, Mar 4, 2020, $0.9M — StartMate, Blackbird

## Investors

- StartMate (https://capitalatlas.ai/funds/startmate) — Seed
- Blackbird (https://capitalatlas.ai/funds/blackbird) — Seed
- NeoTribe Ventures (https://capitalatlas.ai/funds/neotribe-ventures) — Seed